Immunosuppression in ANCA-associated vasculitis.
van der Woude
F J
FJ
Vth Medical University Clinic, Klinikum Mannheim, University of Heidelberg, Mannheim, Germany.
Schmitt
W H
WH
Birck
R
R
Nowack
R
R
Göbel
U
U
Drexler
J M
JM
Hotta
O
O
D019268:Antibodies, Antineutrophil Cytoplasmic / Q000032:analysis*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use*; D005500:Follow-Up Studies; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy* / Q000276:immunology; D006146:Guanidines / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*; D013997:Time Factors
D019268:Antibodies, Antineutrophil Cytoplasmic; D000961:Antilymphocyte Serum; D006146:Guanidines; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; C037258:gusperimus